DLL3 and neoplasm: Among the ligands, DLL1 regulates cell-cell communication, DLL3 inhibits apoptosis induction, DLL4 activates the NF-κB pathway, promoting VEGF expression; JAG-1 promotes angiogenesis, and JAG-2, upon binding Notch-2, activates tumor cell proliferation.